Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Calendar

2019

April 12th at 13.00, Aleksander Cvjetkovic will defend his thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: Isolation strategies and proteomic characterization of extracellular vesicles

2018

May 4th at 09.00 Kristina Johansson will defend her thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: ILC2s and miRNA regulation in allergy and asthma

2017

January 20th at 09.00 Berne Eriksson will defend his thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: COPD: Incidence, prognosis and comorbidity with special focus on heart disease

2016

June 10th at 13.00 Taral Rameshchand Lunavat will defend his thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: Extracellular vesicles and RNA interference i tumors


May 20th at 13.00 Erik Rönmark will defend his thesis.
Location: Europe, Konferenscentrum Wallenberg, Medicinaregatan 20A
Title: The association between eczema, asthma and rhinitis - population studies of prevalence and risk factors among adults

2015

May 21st at 09.00 Stig Hagstad will defend his thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3
Title: COPD Among Never-Smokers. Prevalence, Risk Factors and Comorbidities, The Obstructive Lung Disease in Northern Sweden (OLIN) Studies Thesis XIII

2014

May 8th at 09.30 Taral R Lunavat has his half-time seminar.
Location: Birgit Thilander,  Academicum, Medicinaregatan 3.
Title: Melanoma releases distinct RNAs in subsets of extracellular vesicles.

April 4th at 13:00 Carina Malmhäll will defend her thesis.
Location: Lyktan, Konferenscentrum Wallenberg, Medicinaregatan 20A.
Titel: T cell subsets in asthma and allergy - role of glucocorticoids, plasticity and microRNA-155

2013

June 13th at 09:00 Cecilia Lässer will defend her thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: Exosomes - characterisation of the RNA and protein cargo

June 11th at 13:00 Jonas Eriksson will defend his thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: Prevalence, risk factors and comorbidity of rhinitis, asthma and aspirin-intolerance in West Sweden

February 8th at 13:00 Maria Eldh will defend her thesis.
Location: Arvid Carlsson, Academicum, Medicinaregatan 3.
Title: Exosomes and Exosomal RNA - A Way of Cell-to-Cell Communication.

2012

November 23rd at 13:00 Linda Ekerljung will defend her thesis. Location: Hörsal Ivan Östholm, LNC, Medicinaregatan 13.
Title: Asthma in West Sweden - a translational study from epidemiology to proteomics.

2011

October 18th at 10:00 Jonas Eriksson has his half-time seminar. Location: Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title: Studier av prevalens, riskfaktorer och samvarioation för astma, rinit och salicylidiosynkrasi.

April 28th at 13.00 Allergy Centre Spring meeting.

March 10th at 16:30 Steering Committee meeting for Krefting Research Centre.

March 7th at 13:00 Carina Malmhäll has her half-time seminar. Location: Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title: T helper cells during inflammation in the airways, balance and flexibility.

February 28th at 10:00 You Lu has her half-time seminar. Location: Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title: Study of the balance of T helper cell subsets in response to eosinophilopiesis in airway allergic inflammation.

January 13th at 11:00 Steering Committee meeting for Krefting Research Centre.

January 11th at  15:00  Cecilia Lässer has her half-time seminar at Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title:
Study of RNA-containing exosomes in human: detection, characterisation and capacity for cell-to-cell communication.

2010

December 17th at 10:00 Maria Eldh has her half-time seminar in Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title: Role of shuttle of exosomal RNA between cells in oxidative stress

December 16th at 10:00 Linda Ekerljung has her half-time seminar in Ingegerd Eriksson, Academicum, Medicinaregatan 3.
Title:
Translational asthma study from clinical epidemiology to proteomics aiming to identify clinically relevant asthma phenotypes.

December 16th at 12:00 Steering Committee meeting for Krefting Research Centre

November 2nd at 17:00 Steering Committee meeting for Krefting Research Centre

Please, contact Eva-Marie Romell if you have more dates to put in this calendar.

For international meetings please see below

EAACI news

Remind your MEPs to vote for Allergies!

[2013-10-23]

A Written Declaration on Allergies has been tabled on October 21. In order to be adopted, the majority of the EU Parliament should vote for this by signing. The Written Declaration calls for the implementation of national programmes, better medical training and more scientific research to achieve a better management of the disease, in order to limit its evolution and cost to society.
{loadposition user9}

Call for Meeting Chairs and Venue Proposals

[2019-07-18]

 

There are currently no open calls for Meeting Chairs and Venue Proposals.


[charalampos.kostaras@eaaci.org (Charalampos Kostaras)]

 

There are currently no open calls for Meeting Chairs and Venue Proposals.


COVID-19 resource centre

[2020-04-14]

The EAACI community is united in disseminating new research and knowledge on COVID-19. Find some of the most useful related content on our dedicated webpage, to better serve you and your patients. More resources on COVID-19 will be added as they are released by our community of experts (last update 14.5.2020).

[Ana.Antunes@eaaci.org (Ana Antunes)]

The EAACI community is united in disseminating new research and knowledge on COVID-19. Find some of the most useful related content on our dedicated webpage, to better serve you and your patients. More resources on COVID-19 will be added as they are released by our community of experts (last update 14.5.2020).

In memory of William Frankland (1912-2020)

[2020-01-03]

It is with great regret that we inform you of the passing of William Frankland, MBE at the age of 108. The world-renowned British allergist contributed greatly to progress in our field, including the first controlled clinical trial of allergen immunotherapy, which demonstrated its efficacy (published in 1954), and the development of pollen counting in 1953 and its subsequent popularisation as a regular piece of weather-related information to the public. In June 2015, at the age of 103, he was made a Member of the Order of the British Empire (MBE) for his service to allergy. Well past his 100th birthday, he continued to write for medical journals, attend international scientific conferences and make media appearances, imparting his knowledge and wisdom, and portraying the truly impressive dedication and passion he had for our field of medicine. It was a great privilege for our Academy that Bill Frankland was EAACI president from 1977 to 1980. An inspiration to all of us, he will be sorely missed. The entire EAACI Family extends their deepest condolences to his family and friends.

[Ana.Antunes@eaaci.org (Ana Antunes)]

It is with great regret that we inform you of the passing of William Frankland, MBE at the age of 108. The world-renowned British allergist contributed greatly to progress in our field, including the first controlled clinical trial of allergen immunotherapy, which demonstrated its efficacy (published in 1954), and the development of pollen counting in 1953 and its subsequent popularisation as a regular piece of weather-related information to the public. In June 2015, at the age of 103, he was made a Member of the Order of the British Empire (MBE) for his service to allergy. Well past his 100th birthday, he continued to write for medical journals, attend international scientific conferences and make media appearances, imparting his knowledge and wisdom, and portraying the truly impressive dedication and passion he had for our field of medicine. It was a great privilege for our Academy that Bill Frankland was EAACI president from 1977 to 1980. An inspiration to all of us, he will be sorely missed. The entire EAACI Family extends their deepest condolences to his family and friends.

A new direction for Allergy and Asthma in Europe

[2020-01-03]

The European Parliament Interest Group on Allergy and Asthma convened its first meeting of the 2019-2024 legislature on 20 November 2019, laying out the route to policy successes in Europe for allergy and asthma research, prevention and quality management.

Hosted by Members of the European Parliament (MEPs) Sirpa Pietikäinen and Cristian-Silviu Bușoi, leading Interest Group members, the meeting explored policy improvements to address two of the most prevalent chronic diseases, which affect one in three Europeans and represent an ever-growing burden on societies and healthcare systems.

Allergic diseases and asthma prevention as a priority for the incoming Commission: Wojciech Kalamarz (European Commission DG SANTE) highlighted that chronic diseases’ prevention will be a priority of the Von der Leyen Commission and called on Member States to increase investment in prevention, noting the cost-effectiveness of preventive measures.

Taking action across sectors building on the “exposome” concept: Prof Ioana Agache (Past-President, European Academy of Allergy and Clinical Immunology (EAACI)) advocated for policies looking at the interconnections between human, animal and plant health, and food and water safety to improve prevention in the field of allergy and asthma, which are essentially multifactorial diseases stemming mainly from biological responses to a variety of environmental triggers and less from individual-genetic factors.

Improving allergen labelling to better protect patients: Salvatore D’Acunto (European Commission DG GROW) noted the importance of fragrance allergens labelling for patients. He stated that the Commission is exploring different on- and off-product labelling options, and invited stakeholders to respond to the ongoing public consultation on fragrance labelling.

Interconnecting the health, air quality and climate change agendas came across as a key message from representatives of the WHO European Centre for Environment and Health, the European Environmental Bureau and EAACI. The EU Green Deal has the potential to deliver important steps in this direction, by allowing a cross sectoral approach to air pollution, investment in sustainable agriculture and green financing – with the promise of considerable benefits to the health of future generations. Prof Stefano del Giacco (EAACI Vice-President Education and Speciality) underlined the importance of efficient city planning to reduce risks associated with exposures, as well as registries, machine-learning, and integrated surveillance networks to monitor air quality as tools to provide independent evidence and data support for science-based policy-making. MEP Karima Delli, Chair of the European Parliament TRAN committee, reaffirmed her commitment to reducing emissions from the transport sector, linked with many chronic diseases including allergy and asthma.

A joint call for increased research funding and accelerated uptake of personalised medicine: Reflecting on MEP Dr Cristian-Silviu Bușoi’s perspectives, Dr Amalia-Irina Vlad (European Commission DG RTD) encouraged the allergy and asthma community to seize the opportunity of an enhanced Horizon Europe budget for research and innovation. Prof Vera Mahler (Paul-Ehrlich-Institut) noted that research should address the existing knowledge gap between biomarkers and clinical outcomes so that new treatments and products can be authorised. EAACI President Prof Marek Jutel highlighted the central role of implementing translational research and real world evidence to foster the integration of patient-oriented and population-based studies. Mikaela Odemyr, President of the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), called for universal patient access to personalised medicine which requires a reorientation of healthcare systems, with a focus on individual patients’ needs.

“We need better national programmes and their implementation, early action to protect our biodiversity and improved urban environments to prevent allergies and asthma. We need European Allergy and Asthma reference centre, we need more efforts to improve urban air quality and indoor air quality, we need better information about chemicals in our daily environment and food ingredients. We need to enter a new era where no one suffers from allergy and asthma.” – MEP Sirpa Pietikäinen.

Further insights from the event are available here.

[Ana.Antunes@eaaci.org (Ana Antunes)]

The European Parliament Interest Group on Allergy and Asthma convened its first meeting of the 2019-2024 legislature on 20 November 2019, laying out the route to policy successes in Europe for allergy and asthma research, prevention and quality management.

Hosted by Members of the European Parliament (MEPs) Sirpa Pietikäinen and Cristian-Silviu Bușoi, leading Interest Group members, the meeting explored policy improvements to address two of the most prevalent chronic diseases, which affect one in three Europeans and represent an ever-growing burden on societies and healthcare systems.

Allergic diseases and asthma prevention as a priority for the incoming Commission: Wojciech Kalamarz (European Commission DG SANTE) highlighted that chronic diseases’ prevention will be a priority of the Von der Leyen Commission and called on Member States to increase investment in prevention, noting the cost-effectiveness of preventive measures.

Taking action across sectors building on the “exposome” concept: Prof Ioana Agache (Past-President, European Academy of Allergy and Clinical Immunology (EAACI)) advocated for policies looking at the interconnections between human, animal and plant health, and food and water safety to improve prevention in the field of allergy and asthma, which are essentially multifactorial diseases stemming mainly from biological responses to a variety of environmental triggers and less from individual-genetic factors.

Improving allergen labelling to better protect patients: Salvatore D’Acunto (European Commission DG GROW) noted the importance of fragrance allergens labelling for patients. He stated that the Commission is exploring different on- and off-product labelling options, and invited stakeholders to respond to the ongoing public consultation on fragrance labelling.

Interconnecting the health, air quality and climate change agendas came across as a key message from representatives of the WHO European Centre for Environment and Health, the European Environmental Bureau and EAACI. The EU Green Deal has the potential to deliver important steps in this direction, by allowing a cross sectoral approach to air pollution, investment in sustainable agriculture and green financing – with the promise of considerable benefits to the health of future generations. Prof Stefano del Giacco (EAACI Vice-President Education and Speciality) underlined the importance of efficient city planning to reduce risks associated with exposures, as well as registries, machine-learning, and integrated surveillance networks to monitor air quality as tools to provide independent evidence and data support for science-based policy-making. MEP Karima Delli, Chair of the European Parliament TRAN committee, reaffirmed her commitment to reducing emissions from the transport sector, linked with many chronic diseases including allergy and asthma.

A joint call for increased research funding and accelerated uptake of personalised medicine: Reflecting on MEP Dr Cristian-Silviu Bușoi’s perspectives, Dr Amalia-Irina Vlad (European Commission DG RTD) encouraged the allergy and asthma community to seize the opportunity of an enhanced Horizon Europe budget for research and innovation. Prof Vera Mahler (Paul-Ehrlich-Institut) noted that research should address the existing knowledge gap between biomarkers and clinical outcomes so that new treatments and products can be authorised. EAACI President Prof Marek Jutel highlighted the central role of implementing translational research and real world evidence to foster the integration of patient-oriented and population-based studies. Mikaela Odemyr, President of the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), called for universal patient access to personalised medicine which requires a reorientation of healthcare systems, with a focus on individual patients’ needs.

“We need better national programmes and their implementation, early action to protect our biodiversity and improved urban environments to prevent allergies and asthma. We need European Allergy and Asthma reference centre, we need more efforts to improve urban air quality and indoor air quality, we need better information about chemicals in our daily environment and food ingredients. We need to enter a new era where no one suffers from allergy and asthma.” – MEP Sirpa Pietikäinen.

Further insights from the event are available here.

EAACI WHITE PAPER

[2018-05-04]

Committed to inscreasing allergy awareness and driving policy changes for improved patient care. The EAACI White Paper tackles research-innovation-quality of care nexus for allergic diseases and asthma.

Read here the EAACI White Paper

[kendra.zuber@eaaci.org (Kendra Zuber)]

Committed to inscreasing allergy awareness and driving policy changes for improved patient care. The EAACI White Paper tackles research-innovation-quality of care nexus for allergic diseases and asthma.

Read here the EAACI White Paper

EAACI PAAM 2011 Early Fee Registration Deadline – 15 August 2011

[2011-07-22]

The 2nd Pediatric Allergy and Asthma Meeting, PAAM 2011, will be held in the wonderful city of Barcelona, Spain, 13 – 15 October 2011, and will be attended by internationally renowned speakers from around the world. The scientific programme addresses not only specialists in pediatric allergology, but...

Read more


Nomination to PhARF Award 2011

[2010-11-16]

PhARF is a collaboration between Uppsala University and Phadia AB.  It is based on an international Scientific Committee comprised of internationally recognized scientists in the field of allergy. The committee meets once a year to select candidates for the Award.  Now is the time to nominate to the PhARF Award 2011.  The deadline for Nomination is December 31st, 2010.  The Award amounts to USD 50.000. 

Read more

Christian Virchow

[2010-07-01]

This month, Prof. J. Christian Virchow has granted an interview to Website Management Team during the 29th EAACI Congress in London.  He shares his experience as an SPC Coordinator in Congresses.  Click here to read the entire interview.

Read more


Read more


EAACI Membership Survey

[2012-01-10]

The European Academy for Allergy and Clinical Immunology (EAACI) has grown to become a very important medical association in Europe. We are proud that our community of medical professionals includes about 7’000 clinicians, academics and researchers.

Read more

Contact Information

Krefting Research Centre University of Gothenburg

P.O. Box 424, SE-405 30 Göteborg

Visiting Address:
Medicinaregatan 1F

Phone:
+46 31 786 67 16

Page Manager: Marie Megitt|Last update: 3/12/2019
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?